
Florida Attorney General Ashley Moody said the antitrust probes into Facebook don’t have any common case studies to draw from in deciding how to move forward, according to a report by CNBC.
Florida recently announced it is participating in the probe, which also involves six other states as well as the District of Columbia, noted New York State Attorney General Letitia James.
“It’s an entirely different way of dealing with a monopoly,” Moody said. “We will continue to share information [with the other states and D.C.] as we work through this investigation. Depending upon what we ultimately find, that may indicate how we further collaborate.”
A separate investigation by the Federal Trade Commission (FTC) is already underway. Facebook and the FTC reached a US$5 billion settlement in July over issues concerning privacy.
Facebook Founder and CEO Mark Zuckerberg has spoken against breaking up the company, saying it would harm efforts to stop the spreading of false information and content that violates the company’s policies.
Attorneys general have also started to investigate Google over antitrust concerns, with more than 30 participating in that effort. The bipartisan effort is being spearheaded by Texas. If Google is found to have broken antitrust laws, its business model could be severely harmed. The search engine could be compelled to change the way it categorizes results and pay billions of dollars in fines, as it already has in Europe. Regulators could even force the company to let go of profitable businesses like YouTube.
“I continue to be concerned with the aggregation of data in the hands of a few and am always watchful of any monopoly,” said Mississippi Attorney General Jim Hood. “As attorneys general, we need to evaluate and address specific conduct, utilizing our existing antitrust and consumer protection laws.”
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas